Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase II Evaluation of Nivolumab, a Fully Human Antibody against PD - 1, in the Treatment of Persistent or Recurrent Cervical Cancer
IRB NRG-GY002
CC 15-763
Hospital Fairview, Hillcrest, Main Campus
Phase Phase 2
Disease Gynecologic
Drug Nivolumab
